DOI:
10.1055/s-00000034
Klinische Pädiatrie
LinksClose Window
References
George RE, Sanda T, Hanna M. et al.
Activating mutations in ALK provide a therapeutic target in neuroblastoma.
Nature 2008;
455: 975-978
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.